The new epidemiology of primary biliary cirrhosis

Seminars in Liver Disease

Volumn 34, Issue 3, 2014, Pages 318-328

  Griffiths, Laura ^a   Dyson, Jessica K ^b   Jones, David E J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

epidemiology; primary biliary cirrhosis

Indexed keywords

MITOCHONDRION ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HUMAN; LIVER FUNCTION TEST; MOLECULAR EPIDEMIOLOGY; PHENOTYPE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RARE DISEASE; TOXIC WASTE; AUTOIMMUNITY; ENVIRONMENT; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INTRAHEPATIC BILE DUCT; LIVER CIRRHOSIS, BILIARY; RISK FACTOR; TIME;

AUTOIMMUNITY; BILE DUCTS, INTRAHEPATIC; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER CIRRHOSIS, BILIARY; PREVALENCE; RISK FACTORS; TIME FACTORS;

EID: 84905036282     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0034-1383730     Document Type: Article

References (55)

1. Triger D. R., Berg P. A., Rodes J. Epidemiology of primary biliary cirrhosis. Liver: 1984; 4 3 195 200
2. Invernizzi P., Selmi C., Ranftler C., Podda M., Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis: 2005; 25 3 298 310
3. Lindor K. D., Gershwin M. E., Poupon R., Kaplan M., Bergasa N. V., Heathcote E. J. AASLD. Primary Biliary Cirrhosis. Hepatology: 2009; 50 1 291 230
4. Oertelt S., Rieger R., Selmi C., et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology: 2007; 45 3 659 665
5. Kingham J. G., Parker D. R. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut: 1998; 42 1 120 122
6. James O. FW, Bhopal R., Howel D., Gray J., Burt A. D., Metcalf J. V. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology: 1999; 30 2 390 394
7. Metcalf J. V., Bhopal R. S., Gray J., Howel D., James O. F. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol: 1997; 26 4 830 836
8. Rautiainen H., Salomaa V., Niemelå S., et al. Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. Scand J Gastroenterol: 2007; 42 11 1347 1353
9. Danielsson A., Boqvist L., Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology: 1990; 11 3 458 464
10. Löfgren J., Järnerot G., Danielsson D., Hemdal I. Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden. Scand J Gastroenterol: 1985; 20 5 647 650
11. Kim W. R., Lindor K. D., Locke G. R. III., et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology: 2000; 119 6 1631 1636
12. Farrell G. C. Primary biliary cirrhosis in Asians: less common than in Europeans, but just as depressing. J Gastroenterol Hepatol: 2008; 23 4 508 511
13. Metcalf J., James O. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis: 1997; 17 1 13 22
14. Robson S. C., Hift R. J., Kirsch R. E. Primary biliary cirrhosis. A retrospective survey at Groote Schuur Hospital, Cape Town. S Afr Med J: 1990; 78 1 19 22
15. Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun: 2010; 34 3 J300 J306
16. Su C. W., Hung H. H., Huo T. I., et al. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years. Liver Int: 2008; 28 9 1305 1313
17. Inoue K., Hirohara J., Nakano T., et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver: 1995; 15 2 70 77
18. Mori M. TA, Kojima M., et al. Nationwide survey of intractable hepatic disorders in Japan. In: Welfare MoHa., ed. Annual Report of Research Committee on Epidemiology of Intractable Diseases. Nagoya, Japan Research Committee on Epidemiology of Intractable Diseases: 1997
19. Liu H., Liu Y., Wang L., et al. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol: 2010; 10 100
20. Watson R. G., Angus P. W., Dewar M., Goss B., Sewell R. B., Smallwood R. A. Melbourne Liver Group Low prevalence of primary biliary cirrhosis in Victoria, Australia. Gut: 1995; 36 6 927 930
21. Sood S., Gow P. J., Christie J. M., Angus P. W. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology: 2004; 127 2 470 475
22. Myers R. P., Shaheen A. A., Fong A., et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology: 2009; 50 6 1884 1892
23. Witt-Sullivan H., Heathcote J., Cauch K., et al. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology: 1990; 12 1 98 105
24. Sherlock S. Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology: 1959; 37 574 586
25. Sherlock S., Scheuer P. J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med: 1973; 289 13 674 678
26. Metcalf J. V., Mitchison H. C., Palmer J. M., Jones D. E., Bassendine M. F., James O. F. Natural history of early primary biliary cirrhosis. Lancet: 1996; 348 9039 1399 1402
27. Prince M. I., Chetwynd A., Diggle P., Jarner M., Metcalf J. V., James O. F. The geographical distribution of primary biliary cirrhosis in a well-defined cohort. Hepatology: 2001; 34 6 1083 1088
28. McNally R. J., Ducker S., James O. F. Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis. Hepatology: 2009; 50 4 1169 1174
29. Ala A., Stanca C. M., Bu-Ghanim M., et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology: 2006; 43 3 525 531
30. Triger D. R. Primary biliary cirrhosis: an epidemiological study. BMJ: 1980; 281 6243 772 775
31. Gershwin M. E., Selmi C., Worman H. J., et al. USA PBC Epidemiology Group. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology: 2005; 42 5 1194 1202
32. Howel D., Fischbacher C. M., Bhopal R. S., Gray J., Metcalf J. V., James O. F. An exploratory population-based case-control study of primary biliary cirrhosis. Hepatology: 2000; 31 5 1055 1060
33. Prince M. I., Ducker S. J., James O. FW. Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut: 2010; 59 4 508 512
34. Carbone M., Mells G. F., Pells G., et al. UK PBC Consortium. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology: 2013; 144 3 560 569, e7, quiz e13-e14
35. Pells G., Mells G. F., Carbone M., et al. UK-PBC Consortium. The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort. J Hepatol: 2013; 59 1 67 73
36. Mells G. F., Pells G., Newton J. L., et al. UK-PBC Consortium. Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology: 2013; 58 1 273 283
37. Parés A., Caballería L., Rodés J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology: 2006; 130 3 715 720
38. Corpechot C., Abenavoli L., Rabahi N., et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology: 2008; 48 3 871 877
39. Corpechot C., Chazouillères O., Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol: 2011; 55 6 1361 1367
40. Alvaro D., Invernizzi P., Onori P., et al. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol: 2004; 41 6 905 912
41. Reddy A., Prince M., James O. FW, Jain S., Bassendine M. F. Tamoxifen: a novel treatment for primary biliary cirrhosis? Liver Int: 2004; 24 3 194 197
42. Jones D. EJ, Sutcliffe K., Pairman J., Wilton K., Newton J. L. An integrated care pathway improves quality of life in Primary Biliary Cirrhosis. QJM: 2008; 101 7 535 543
43. Mason A., Luketic V., Lindor K., et al. Farnesoid-X receptor agonists: a new class of drug for the treatment of PBC? An international study evaluating the addition of INT-747 to ursodeoxycholic acid. J Hepatol: 2010; 52 S1 S2
44. Newton J. L., Pairman J., Sutcliffe K., Wilton K., Jones D. EJ. A predictive model for fatigue and its etiologic associations in primary biliary cirrhosis. Clin Gastroenterol Hepatol: 2008; 6 2 228 233
45. Hirschfield G. M., Liu X., Xu C., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med: 2009; 360 24 2544 2555
46. Mells G. F., Floyd J. AB, Morley K. I., et al. UK PBC Consortium; Wellcome Trust Case Control Consortium 3. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet: 2011; 43 4 329 332
47. Liu J. Z., Almarri M. A., Gaffney D. J., et al. Dense fine-mapping study identifies novel disease loci and implicates coding and non-coding variation in primary biliary cirrhosis risk. Nat Genet: 2012; 44 1137 1141
48. Hirschfield G. M., Liu X., Han Y., et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet: 2010; 42 8 655 657
49. Jones D. EJ, Mells G. The genetics of primary biliary cirrhosis: the revolution moves on. Hepatology: 2011; 53 1 362 364
50. Walden H. R., Kirby J. A., Yeaman S. J., Gray J., Jones D. E., Palmer J. M. Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway. Hepatology: 2008; 48 6 1874 1884
51. Yeaman S. J., Kirby J. A., Jones D. EJ. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev: 2000; 174 238 249
52. Long S. A., Quan C., Van de Water J., et al. The aetiology of primary biliary cirrhosis: connecting xenobiotics to anti-mitochondrial antibodies by ab initio quantum chemistry. Hepatology: 2001; 34 341A
53. Long S. A., Quan C., Van de Water J., et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol: 2001; 167 5 2956 2963
54. Leung P. S., Quan C., Park O., et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol: 2003; 170 10 5326 5332
55. Leung P. SC, Park O., Tsuneyama K., et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol: 2007; 179 4 2651 2657